Overview
Headquarters
Colmenar Viejo, Madrid
Pharma Mar SA manufactures drug and medicines. The Company offers cancer treatment through discovering, developing, producing, and marketing innovative drugs of marine origin. Pharma Mar operates throughout Spain. PHARMA MAR SA is located in TRES CANTOS, Spain and is part of the Pharmaceutical Manufacturing Industry. There are 14 companies in the PHARMA MAR SA corporate family. PHARMA MAR SA is located in TRES CANTOS, Spain and is part of the Pharmaceutical Manufacturing Industry. There are 14 companies in the PHARMA MAR SA corporate family. PharmaMar is fishing for a cure for cancer. The company develops tumor-fighting compounds from a library of thousands of marine organisms. Its Yondelis drug (codeveloped with Johnson & Johnson Pharmaceutical Research & Development) has received approval in about 80 countries to treat soft-tissue sarcoma and is being studied for use with other cancers. Other cancer treatment drugs lie in its pipeline. Biotech subsidiaries include Genomica (molecular diagnostics and DNA testing) and Sylentis (therapeutic approaches based on gene silencing). PharmaMar sold its woodcare and paints unit Xylazel to Akzo Nobel in 2017. Try D&B Hoovers Free PharmaMar is fishing for a cure for cancer. The company develops tumor-fighting compounds from a library of thousands of marine organisms. Its Yondelis drug (codeveloped with Johnson & Johnson Pharmaceutical Research & Development) has received approval in about 80 countries to treat soft-tissue sarcoma and is being studied for use with other cancers. Other cancer treatment drugs lie in its pipeline. Biotech subsidiaries include Genomica (molecular diagnostics and DNA testing) and Sylentis (therapeutic approaches based on gene silencing). PharmaMar sold its woodcare and paints unit Xylazel to Akzo Nobel in 2017.
